Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: t36 who wrote (575)	4/3/1997 12:25:00 AM
From: George T. Santamaria	of 6136

Can't answer that one but will offer a few possibilities: Someone once said a stock thrives on Romance and dies on statistics. In this case, we all know what the romance is but the grim statistics are that Agouron has to build sales real fast, pay big salaries to a large sales force and all this has to hit a fairly narrow market window to succeed. If the sales grow faster than projected, we can breathe a sign of relief. Everyone is afraid of the market power of AGPH's competitors. Somebody thinks that a few rate increases in the Fed will actually have an effect on whether I think I should buy AGPH or buy bonds. Somebody thinks all biotechs always lose money. NASDAQ stocks are going down, AGPH is a stock

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next